Lujain Al-Momen

🦠 Infectious Diseases Fellow @E1_Cluster

[Lujain Al-Momen @lmmomen91]

اللهم اجعل #الطب شفيعاً لي يوم تسألني عن شبابي فيما أفنيته ..

[1-min ID consult @1min_IDconsult]

【AIDS-associated Cancers】

Let's review AIDS-defining cancers and non-AIDS-defining cancers!

Level: Basic to Intermediate

#IDMedEd #IDFellow #IMResident #HIV #Cancer

[AlMoosa Academics @AcademicAlmoosa]

🦠 Infectious Disease Club

📅 1 Sep 2026 | ⏰ 8–10 PM
📍 Almoosa Specialist Hospital – NT, 16th Floor
🎟️ Register by scanning the QR Code on the poster.
#InfectiousDisease #Healthcare #MedicalEducation #InfectiousDiseases #MedEd #HealthcareEducation #SaudiHealthcare

[Lujain Al-Momen @lmmomen91]

@alsaeedalih بالتوفيق دكتور علي

[Dr Ihab Suliman @IhabFathiSulima]

لماذا يأتي قلم الإبينفرين EpiPen عادةً على شكل حقنتين بدلًا من حقنة واحدة فقط؟ 💉💉

وما السبب الطبي وراء ضرورة حمل الجرعة الثانية؟

[NEJM @NEJM]

A 61-year-old man with prolonged neutropenia after chemotherapy for AML was evaluated for persistent fever despite antimicrobial therapy. Physical examination was notable for a skin macule with central necrosis on the chest.

Read the full case details in the Images in Clinical Medicine article “Disseminated Fusariosis”: https://t.co/zjZ0oMCrHN

[Lujain Al-Momen @lmmomen91]

@IDWeekmtg @IdBowl What is Leptospirosis

[IDProfessionals @IDprofs]

Enhance your exam readiness while strengthening your clinical decision-making in adult infectious diseases. Join the Adult ID Board Review Course. Learn more and register: https://t.co/N8LYgezF2e
#KSAIDWeek2026

[Clinical Infectious Diseases @CIDJournal]

Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

✅ Just Accepted
🔗 https://t.co/VxaIvZFQYQ

[IDProfessionals @IDprofs]

Submit your clinical case for the 10th Annual ID Week 2026! Top 3 cases will be selected for a 10-minute oral presentation, with winners recognized during the congress.

Deadline: 01 Sep 2026
02–03 Oct | Abu Dhabi
https://t.co/n8xHJhYoXg

#IDWeek2026 #InfectiousDiseases

[Lujain Al-Momen @lmmomen91]

@sul6aneez91 ماشالله. الف مبرووك دكتور. موفقين الله ينفع بكم

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

💥IDSA AMR Guidance 2026 Now published in CID💥
Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
IDSA 2026 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
🔺ESBL , AmpC Enterobacterales
🔺CRE
🔺DTR P. aeruginosa
🔺CRAB
🔺Stenotrophomonas maltophilia #IDXposts

https://t.co/eddrrRIkMI

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕✨🟢Clinical guideline highlights for the hospitalist: Updates on the treatment of drug-susceptible and drug-resistant tuberculosis
🔺2025 ATS/CDC/ERS/IDSA clinical treatment guidelines
🔺Rifampin exchanged for Rifapentine
🔺Elimination of Ethambutol, Addition of Moxifloxacin
🔺 Duration 🔽 from 4 month to 2 month continuation phase
🔺Logistical challenges related to rifapentine
🔺Further research is needed to identify predictors of treatment tolerability #idxposts
https://t.co/3GiysTAuL8

[خالد القرني 🇸🇦Khaled Alqarni @DrKhaledAlqarni]

الدورة الثالثة والثلاثون لمراجعة البورد في الطب الباطني — 2026

ابدأ التدريب وكأنه يوم الاختبار!

3 أيام مكثفة في مستشفى الملك فيصل التخصصي ومركز الأبحاث (3-5 سبتمبر)، يخوض خلالها المشارك اختبارًا محاكيًا يوميًا (100 سؤال، 150 دقيقة) بنفس ظروف اختبار الهيئة السعودية للتخصصات الصحية الفعلي — أي 3 اختبارات كاملة خلال أيام الدورة.

بعد كل اختبار، مراجعة مكثفة مع استشاريين متخصصين تغطي جميع التخصصات الفرعية، بالإضافة إلى مجموعة واتساب تفاعلية خلال أيام الدورة.

#Matching2026
#InternalMedicineBoard
#InternalMedicine
#SCFHS
#SaudiBoard

[Lujain Al-Momen @lmmomen91]

@abdulhamid_199 Lichen planus

[IDProfessionals @IDprofs]

Happening today at 7:00 PM KSA!
Join the IDIC 2026 webinar, “Challenging Transplant ID Cases Across the Kingdom.”
2 CME Points | https://t.co/CO6nQP6jFS
#IDIC2026 #TransplantID

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥🔥IDSA AMR Guidance 2026🔥🔥

🔺Notable Updates from the 2024 IDSA AMR Guidance Document

IDSA 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

🔺ESBL, AmpC Enterobacterales
🔺CRE
🔺DTR P. aeruginosa
🔺CRAB
🔺Stenotrophomonas maltophilia

Including updates in antimicrobial selection, dosing strategies, and management approaches.

🔺Meropenem dosing update: individualized dosing approach (1–2 g IV q8h) with higher doses considered in selected clinical scenarios.

Info inspired / credit to @RabeaAgeeli , #IDXposts
https://t.co/lfAjZU2zHQ

[Lujain Al-Momen @lmmomen91]

@IDWeekmtg @IdBowl What is Madura foot

[Lujain Al-Momen @lmmomen91]

@maha_mssh ♥️♥️♥️♥️♥️

[IDProfessionals @IDprofs]

Your research deserves a live audience. ✨

Submit your Oral Abstract to IDIC 2026 and present your findings in front of distinguished specialists, researchers, and healthcare leaders.

Submit Now: https://t.co/K83ojXj0Vv
#IDIC2026 #OralAbstracts #ScientificPresentation

[IDProfessionals @IDprofs]

Your infection prevention and control project could inspire the next breakthrough in healthcare. Submit to the Excellence in Infection Prevention and Control Projects 2026 and showcase your impact at #KSAID2026. 👉 https://t.co/O2CClOXFxo #InfectiousDiseases #DiseasePrevention